MAPK10 and Parkinson disease: Inhibiting the ASK1-JNK3 pathway by disrupting the interaction between β-arrestin-2 and JNK3 has been revealed as an effective strategy for preventing dopaminergic neuron loss in PD (Pan et al., 2015).